SANUWAVE Health, Inc.SNWV
What SANUWAVE Health, Inc. does.
Sanuwave is a medical device company providing directed energy products into the wound care space. Our mission is to improve patient lives and outcomes by developing and marketing effective, easy to use products to decrease wound burden, lessen healing times, and reduce patient pain.
Our focus is regenerative medicine utilizing noninvasive ultrasound to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The Company’s patented and FDA cleared product is the UltraMIST ® system, which is used to treat a variety of acute and chronic wounds. The Company is backed by an intellectual property (“IP”) portfolio of over 60 patents.
In the year ended December 31, 2025 , we had total revenues of $44.1 million , a 35% increase from revenues of $32.6 million in the year ended December 31, 2024 . UltraMIST systems and consumables represented approximately 99% of 2025 revenues versus 98% of revenues in 2024.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.1M | $13.0M | $16.7M | $20.4M | $32.6M | $44.1M |
| Net income | -$30.9M | -$27.3M | -$10.3M | -$25.8M | -$33.1M | $11.8M |
| Free cash flow | -$12.8M | -$6.9M | — | -$4.5M | $2.0M | $1.9M |
More on SNWV.
- SANUWAVE Health, Inc. summary
- SANUWAVE Health, Inc. financial statements
- SANUWAVE Health, Inc. key metrics
- SANUWAVE Health, Inc. health scores and style box
- SANUWAVE Health, Inc. earnings
- SANUWAVE Health, Inc. dividends
- SANUWAVE Health, Inc. valuation
- SANUWAVE Health, Inc. ownership and insiders
- SANUWAVE Health, Inc. peers
Figures from SANUWAVE Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.